UKRG Handbook  Radiochemical Purity Systems of Radiopharmaceuticals

 

Thin-layer chromatography of technetium radiopharmaceuticals

 

Stationary phases:

            ITLC-SG         Instant thin-layer chromatography, silica gel, Pal Gelman Laboratory

            ITLC-SA         Instant thin-layer chromatography, silicic acid, Gelman (No longer available)

            3MM               Whatman 3MM chromatography paper

            No 1                Whatman No 1 chromatography paper

            silica gel            Silica gel 60, e.g. Merck

            alumina aluminium oxide, Bakerflex

            cellulose           cellulose, e.g. Merck

 

Mobile phases:

            butanone = 2-butanone = methyl ethyl ketone = MEK

1 M sodium acetate = 82 mg/mL anhydrous sodium acetate

                        or 136 mg/mL sodium acetate trihydrate

0.1 M citrate = 21 mg/mL monosodium citrate dihydrate

1 M ammonium acetate = 77 mg/mL ammonium acetate

mixtures of volatile solvents should be made freshly each day

 

 

Radiopharma-ceutical

Stationary phase

Mobile

phase

Rf

RH-Tc

Rf

TcO4

Rf

Tc-bound

99mTc-pertechnetate

ITLC-SG

acetone or saline

0.0

1.0

-

99mTc-MDP

ITLC-SG or 3MM

acetone

0.0

1.0

0.0

99mTc-MDP

ITLC-SG

1 M sodium acetate or saline

0.0

1.0

1.0

99mTc-DTPA

ITLC-SG or 3MM

Acetone

0.0

1.0

0.0

99mTc-DTPA

ITLC-SG or 3MM

saline

0.0

1.0

1.0

99mTc-colloid

ITLC-SG or 3MM

acetone or saline

0.0

1.0

0.0

99mTc-DMSA

3MM

acetone

0.0

1.0

0.0

99mTc-DMSA

ITLC-SA

butanol acidified with 0.3 M HCl

0.0

0.9

0.5

99mTc-MAA

ITLC-SG or 3MM

acetone or saline

0.0

1.0

0.0

99mTc-pyrophosphate

ITLC-SG or 3MM

acetone

0.0

1.0

0.0

99mTc-pyrophosphate

ITLC-SG

water

0.0

1.0

1.0

99mTc-HSA

ITLC-SG or 3MM

acetone

0.0

1.0

0.0

99mTc-HSA

ITLC-SG

strip should be pre-saturated with human serum albumin and dried

ethanol-ammonia-water (2:1:5)

0.0

1.0

1.0

99mTc-HIG

ITLC-SG or 3MM

acetone, saline, or 0.1 M citrate

0.0

1.0

0.0

99mTc(V)-DMSA

ITLC-SG

butanone

0.0

1.0

0.0

99mTc(V)-DMSA

ITLC-SG

saline

0.0

1.0

1.0

99mTc(V)-DMSA

silica gel

butanol-acetic acid- water (3:2:3)

0.0

0.8

0.5

99mTc-IDAs

ITLC-SA

20% sodium chloride

0.0

1.0

0.0

99mTc-IDAs

3MM spot must be dry

butanone

0.0

0.9

0.0

99mTc-IDAs

ITLC-SG

water or 50% acetonitrile

0.0

1.0

1.0

99mTc-sestamibi

Alumina

Pre-spot with ethanol; do not allow spot to dry

ethanol

0.0

0.0

1.0

99mTc-tetrofosmin

ITLC-SG

spot must be dry

acetone-dichloromethane (35:65)

0.0

1.0

0.5

99mTc-MAG3

ITLC-SG

ethyl acetate-butanone  (3:2)

0.0

1.0

0.0

99mTc-MAG3

ITLC-SG

50% acetonitrile

0.0

1.0

1.0

99mTc-exametazime

ITLC-SG

butanone

0.0

1.0

1.0

99mTc-exametazime

ITLC-SG

saline

0.0

1.0

0.0

99mTc-exametazime

No 1

50% acetonitrile

0.0

1.0

1.0

99mTc-sulesmurab (Leukoscan)

ITLC-SG or 3MM

acetone, saline, or 0.1 M citrate

0.0

1.0

0.0

99mTc-depreotide (Neospect)

ITLC-SG

saturated solution of sodium chloride

0.0

1.0

0.0

99mTc-depreotide (Neospect)

ITLC-SG

1 M ammonium acetate-methanol (1:1)

0.0

1.0

1.0

                                                                                                                                               

 

Substitutions:

in most cases, 2-butanone (methyl ethyl ketone, MEK) can be substituted for acetone

in most cases, water can be substituted for saline

in most cases, Whatman No 1 can be substituted for Whatman 3MM paper

ACD can be substituted for 0.1 M citrate

 

 

 

 

Thin-layer chromatography of other radiopharmaceuticals

 

Radiopharma-ceutical

Stationary

phase

Mobile

phase

Rf

free

Rf bound

14C-urea

cellulose

butanol-water-acetic acid (12:5:3)

?

0.6

123/131I-hippuran

silica gel

chloroform-acetic acid (9:1)

0.0

0.2-0.3

123/131I-MIBG

silica gel

ethyl acetate-ethanol (1:1)

0.6

0.0

111In-DTPA

ITLC-SG

10% ammonium acetate- methanol (1:1)

0.1

1.0

111In-octreotide

ITLC-SG

0.1 M citrate buffer pH 5

1.0

0.0

18F-FDG

silica gel

acetonitrile-water (95:5)

0.0

0.6

123I- ioflupane

ITLC-SG spot must be dry

chloroform-methanol (9:1)

0.0

1.0

123I-iomazenil

silica gel

ethyl acetate-ammonium hydroxide (200:1)

0.0

0.7

123I-iomazenil

silica gel

chloroform-acetic acid- water (65:35:5)

0.0

0.3

131I-iodocholesterol

silica gel

chloroform-ethanol (1:1)

0.0

0.66

           

Solid-phase extraction cartridge methods (e.g. Sep-Pak)

 

General procedure:

1.      Pre-wet (“activate”) cartridge with 2-5 mL ethanol or methanol.

2.      Prepare cartridge with 2-10 mL of preparation solvent.

3.      Place a drop of the radiopharmaceutical in the inlet of the cartridge.

4.      Elute sequentially with 2-10 mL quantities of eluates A, B, C and collect each in a separate tube; after the last eluate, force air through the cartridge to dry it.

5.      Place the cartridge in another tube for measurement of residual activity.

6.      Measure the activity in each tube in an ionisation chamber.

7.      Calculate radiochemical purity as per table.

 

Radiopharma-ceutical

Type of cartridge

Prepar-ation solvent

A

B

C

D

Purity

99mTc-sestamibi

alumina N

0.5 mL ethanol

10 mL ethanol

cartridge residue

 

 

A/total

99mTc-

sestamibi

C18

2 mL saline

2 mL saline

5 mL ethanol

cartridge residue

 

B/total

99mTc-

tetrofosmin

C18

2 mL saline

2 mL saline

5 mL ethanol

cartridge residue

 

B/total

99mTc-

tetrofosmin

silica

5 mL saline then 1 mL air

 

10 mL  methanol-water (70:30) over 2 minutes cartridge residue     B/total

99mTc-

tetrofosmin

silica

5 mL saline then 1 mL air

 

10 mL  methanol-water (70:30) over 2 minutes 10 mL methanol-saline (80:20) cartridge residue   B/total

99mTc-MAG3

C18

10 mL

1 mM HCl

10 mL

1 mM

HCl

10 mL 50% ethanol

cartridge residue

 

B/total

99mTc-MAG3

C18

10 mL

1 mM HCl

5 mL

1 mM

HCl

5 mL 0.5% ethanol in PB

10 mL 7% ethanol in PB

cartridge residue

C/total

99mTc-exametazime

C18

5 mL saline

5 mL saline

cartridge residue

 

 

B/total

99mTc-exametazime

C18

5 mL saline

5 mL saline

5 mL ethanol

cartridge residue

 

B/total

111In-

octreotide

C18

10 mL water

5 mL water

5 mL methanol

cartridge residue

 

B/total

123I-ioflupane

C18

5 mL water

5 mL water

5 mL ethanol

cartridge residue

 

B/total

123/131I-MIBG

C18

5 mL water

5 mL water

10 mL PB-THF (3:1)

cartridge residue

 

B/total

123/131I-MIBG

C18

5 mL water

5 mL

10 mM NaOH

cartridge residue

 

 

B/total

 

Preparation of reagents:

1 mM HCl (0.001 M HCl) = 1 mL conc HCl per litre of distilled water.

PB for MAG3 = 0.01 M (10 mM) sodium phosphate buffer pH 6

Prepare 100 mL 0.01 M monosodium phosphate solution (NaH2PO4).  Prepare 20 mL 0.01 M disodium phosphate solution (Na2HPO4).  Add 10 mL disodium phosephate solution to 100 mL monosodium phosphate solution.  pH should still be below 6.  Add disodium phosphate solution dropwise until pH of 6 is obtained.

PB for MIBG = 0.1 M (100 mM) monosodium phosphate (NaH2PO4)

THF = tetrahydrofuran

10 mM NaOH (0.01 M NaOH) = 0.4 g dissolved in 1 litre of distilled water

            or dilute 1 mL 1 M NaOH with 99 mL distilled water

 

Cartridges can be re-used after decay of radioactivity

 

99mTc-exametazime Extraction Method

1. Prepare a 10 ml test tube containing 3 ml of ethyl acetate and 3 ml of 0.9% w/v sodium chloride solution.
2  Add several drops of  99mTc-exametazime (immediately after reconstitution).
3 Cap the tube and mix on a vortex mixer for 1 min.
4 Allow the tube to stand for 1 min to allow the two phases to separate.
5 Remove the top layer using a pipette into another test tube.
6 Measure the activities in each layer.
7 Calculate the % lipophilic complex as follows:-
  % Primary complex =    Activity in the ethyl acetate layer   x 100      (should be greater than 80 %)
                                                 Total activity in both layers

 

Back to Radiopharmacy Handbook Index